Searched for
DADHA PHARMACEUTICALS
RIL takes on Amazon in e-pharmacy biz, acquires majority stake in Netmeds for Rs 620 croreReliance Retail Ventures has acquired a majority stake in Vitalic Health Pvt. Ltd and its subsidiaries -- collectively known as Netmeds -- ...- Reliance plans to buy e-pharmacy NetmedsThe conversations between Reliance and Netmeds, which had also held talks with Walmart-owned Flipkart, had been going on before the coronav...
- Buy Sun Pharmaceutical, target Rs 475: Sacchitanand UttekarBuy Sun Pharmaceutical Industries Ltd. at a price target of Rs 475.0 and a stoploss at Rs 443 from entry point.
- Buy Sun Pharma, target Rs 448: Dr CK NarayanBuy Sun Pharmaceutical Industries Ltd. at a price target of Rs 448.0 and a stoploss at Rs 432 from entry point.
- Buy Sun Pharmaceutical Industries, target Rs 655: Gaurav RatnaparkhiBuy Sun Pharmaceutical Industries at a price target of Rs 655 and a stop loss at Rs 588 from the entry point.
- Buy Sun Pharmaceutical Industries, target Rs 520: Manas JaiswalBuy Sun Pharmaceutical Industries Ltd. at a price target of Rs 520.0 and a stop loss at Rs 502 from entry point.
- Buy Sun Pharmaceutical Industries, target Rs 640: Kunal BothraBuy Sun Pharmaceutical Industries Ltd. at a price target of Rs 640.0 and a stop loss at Rs 550 from entry point.
- Sell Sun Pharmaceutical Industries, target Rs 543.60: ICICI DirectSell Sun Pharmaceutical Industries Ltd. at a price target of Rs 543.6 and a stop loss at Rs 559.4 from entry point.
- Buy Sun Pharmaceutical Industries, target Rs 634: Sagar DoshiBuy Sun Pharmaceutical Industries Ltd. at a price target of Rs 634.0 and a stop loss at Rs 575 from entry point.
- Buy Sun Pharmaceutical Industries, target Rs 610: Shrikant ChouhanBuy Sun Pharmaceutical Industries Ltd. at a price target of Rs 610.0 and a stop loss at Rs 565 from entry point.
- Buy Sun Pharmaceutical Industries, target Rs 530: Shrikant ChouhanBuy Sun Pharmaceutical Industries at a price target of Rs 530 and a stop loss at Rs 498 from entry point.
- Buy Sun Pharmaceutical Industries, target Rs 585: Shrikant ChouhanBuy Sun Pharmaceutical Industries at a price target of Rs 585 and a stop loss at Rs 553 from entry point.
- Buy Sun Pharmaceutical Industries Ltd. target Rs 580.0 : Chandan TapariaBuy Sun Pharmaceutical Industries Ltd. at a price target of Rs 580.0 and a stoploss at Rs 535 from entry point.
- Buy Sun Pharmaceutical Industries Ltd. target Rs 562.0 : Dr CK NarayanBuy Sun Pharmaceutical Industries Ltd. at a price target of Rs 562.0 and a stoploss at Rs 545 from entry point.
- Buy Sun Pharmaceutical Industries, target Rs 550: Manas JaiswalBuy Sun Pharmaceutical Industries at a price target of Rs 550 and a stop loss at Rs 520 from entry point.
- Sell Sun Pharmaceutical Industries target Rs 519: Siddharth BhamreSell Sun Pharmaceutical Industries Ltd. at a price target of Rs 519 and a stop loss at Rs 588 from entry point.
- OrbiMed leads $50 million funding round in online pharma marketplace Netmeds.comAdditionally in May earlier this year, ET had reported that MAPE Advisory Group was investing in the still yet-to-be launched Netmeds.com.
- Netmeds.com ties with India Post, plans warehouse in eastPharma aggregator startup Netmeds.com has tied up with India Post as logistics partner for pan India delivery of medicines.
- Online pharmacy Netmeds scheduled to go live by next weekOnline pharmacy Netmeds, which is backed by boutique investment firm MAPE Advisory Services is set to go live next week and targets a marke...
- MAPE Advisory Group to invest Rs 30 crore in NetMeds MarketplaceMAPE Advisory along with founder Pradeep Dadha are initially pumping in Rs 30 crore in the firm, with a commitment to increase it to Rs 60 ...
Load More
